Anterpreet Dua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anterpreet Dua has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Zhuo Sun
Department of Anesthesiology, Perioperative and Pain Medicine, Wellstar MCG Health, Augusta University, Augusta, GA 30912, USA
2 shared publications - Ahmad Mirza
Department of Medicine, Wellstar MCG Health, Augusta University, Augusta, GA 30912, USA
1 shared publication - Javier J. Polania Gutierrez
Anesthesiology, Augusta University Medical College of Georgia, Augusta, USA
1 shared publication - Jungmin On
Anesthesiology, Rush University Medical Center, Chicago, USA
1 shared publication - Miguel Plaza-Lloret
Anesthesiology, Augusta University Medical College of Georgia, Augusta, USA
1 shared publication - Paramvir Singh
Department of Anesthesiology, Perioperative and Pain Medicine, Wellstar MCG Health, Augusta University, Augusta, GA 30912, USA
1 shared publication
Latest Publications
- Open Access
- 21 November 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (12) , 586
Artificial Intelligence in Personalized Pain Medicine: Current Evidence, Clinical Applications and Future Directions
Introduction: Pain is a leading cause of disability because of its subjective, multidimensional and heterogeneous nature. Artificial intelligence (AI), encompassing machine learning (ML), deep learning (DL) and natural language processing (NLP) can integrate multimodal data to support personalized pain care. Personalized pain medicine is defined as the use of patient-specific characteristics to guide individualized assessment, risk stratification and treatment selection. Methods: A structured literature review was conducted in PubMed/MEDLINE, Scopus, Web of Science and Google Scholar (January 2020 to 30 June 2026), supplemented by citation searching for foundational studies. Findings were evaluated descriptively because of heterogeneity in populations, algorithms, outcomes and validation methods. A five-stage evidence-maturity framework was applied to classify applications. Results: Most published work remains at Stages 1–2 (model development and independent validation). Automated facial-pain assessment can achieve high internal performance (F1 91–96%) that declines markedly with subject-independent validation (F1 40–67%). A postoperative external test set of 120 images, exact 0–10 score prediction reached 53%, with a reported mean error of 2.4 points. A Random Forest model predicted postoperative opioid-requirement categories with 72% accuracy, compared with 71% for multinomial logistic regression; sensitivity was 89% for lower and 43% for higher requirements. The small accuracy difference, incomplete calibration and class-distribution reporting limit claims of incremental value. Discussion and Conclusions: AI shows technical promise for automated assessment and risk prediction, but high predictive metrics do not equate to clinical utility. Translation requires external multicenter validation and calibration assessment under clinician supervision and demonstration of improved patient outcomes.
- 21 November 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (12) , 586
Open AccessArtificial Intelligence in Personalized Pain Medicine: Current Evidence, Clinical Applications and Future Directions
Introduction: Pain is a leading cause of disability because of its subjective, multidimensional and heterogeneous nature. Artificial intelligence (AI), encompassing machine learning (ML), deep learning (DL) and natural language processing (NLP) can integrate multimodal data to support personalized pain care. Personalized pain medicine is defined as the use of patient-specific characteristics to guide individualized assessment, risk stratification and treatment selection. Methods: A structured literature review was conducted in PubMed/MEDLINE, Scopus, Web of Science and Google Scholar (January 2020 to 30 June 2026), supplemented by citation searching for foundational studies. Findings were evaluated descriptively because of heterogeneity in populations, algorithms, outcomes and validation methods. A five-stage evidence-maturity framework was applied to classify applications. Results: Most published work remains at Stages 1–2 (model development and independent validation). Automated facial-pain assessment can achieve high internal performance (F1 91–96%) that declines markedly with subject-independent validation (F1 40–67%). A postoperative external test set of 120 images, exact 0–10 score prediction reached 53%, with a reported mean error of 2.4 points. A Random Forest model predicted postoperative opioid-requirement categories with 72% accuracy, compared with 71% for multinomial logistic regression; sensitivity was 89% for lower and 43% for higher requirements. The small accuracy difference, incomplete calibration and class-distribution reporting limit claims of incremental value. Discussion and Conclusions: AI shows technical promise for automated assessment and risk prediction, but high predictive metrics do not equate to clinical utility. Translation requires external multicenter validation and calibration assessment under clinician supervision and demonstration of improved patient outcomes.
- Open Access
- 18 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33928
Spinal Cord Stimulation for the Treatment of Refractory Pain From Tarlov Cysts: A Case Report
Tarlov cysts are extradural meningeal cysts with a collection of cerebrospinal fluid that most often affects sacral nerve roots, causing chronic low back pain and radiculopathy. Still, there is no consensus regarding the best treatment for symptomatic cysts. We describe a patient who developed worsening lower back pain and radiculopathy after interventional drainage and surgical management. Medication and various procedures failed to relieve the pain. Subsequently, the patient received significant pain relief from spinal cord stimulation (SCS). This case provides evidence that SCS could be used to manage refractory pain from Tarlov cysts that have failed to respond to other treatment modalities.
- 18 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33928
Open AccessSpinal Cord Stimulation for the Treatment of Refractory Pain From Tarlov Cysts: A Case Report
Tarlov cysts are extradural meningeal cysts with a collection of cerebrospinal fluid that most often affects sacral nerve roots, causing chronic low back pain and radiculopathy. Still, there is no consensus regarding the best treatment for symptomatic cysts. We describe a patient who developed worsening lower back pain and radiculopathy after interventional drainage and surgical management. Medication and various procedures failed to relieve the pain. Subsequently, the patient received significant pain relief from spinal cord stimulation (SCS). This case provides evidence that SCS could be used to manage refractory pain from Tarlov cysts that have failed to respond to other treatment modalities.
- Open Access
- 1 January 2017
- Published by Biocore Group in International Journal of Anesthesia and Relaxation
- Vol. 1 (1) , 1-3
Radiofrequency Ablation for Treatment of Cervicogenic Headache: Where do we stand?
- 1 January 2017
- Published by Biocore Group in International Journal of Anesthesia and Relaxation
- Vol. 1 (1) , 1-3
Open AccessRadiofrequency Ablation for Treatment of Cervicogenic Headache: Where do we stand?